Novartis profits rise but functional food arm declines
Novartis, the Swiss pharmaceuticals group, has reported a 20 per cent rise in first-quarter profits, exceeding analysts' forecasts, however this was largely a result of strong growth in pharmaceuticals and US business, while the Health and Functional...